Posted On: 07/15/2014 7:51:18 PM
Post# of 4
BFNH Financials 07/15/2014 18:51:20
BioForce Nanosciences Holdings, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 27 -
Cost of Revenue - -
Gross Profit 27 -
Operating Expenses
Research and Development - -
Sales, General and Admin. 5 4
Non-Recurring Items - -
Other - -
Operating Income 22 (4)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax 22 (4)
Interest Expense - -
Earnings Before Tax 22 (4)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 22 (4)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 22 (4)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 22 (4)
BioForce Nanosciences Holdings, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 27 -
Cost of Revenue - -
Gross Profit 27 -
Operating Expenses
Research and Development - -
Sales, General and Admin. 5 4
Non-Recurring Items - -
Other - -
Operating Income 22 (4)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax 22 (4)
Interest Expense - -
Earnings Before Tax 22 (4)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations 22 (4)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 22 (4)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 22 (4)
(0)
(0)Scroll down for more posts ▼
